Journal Article

Phase II-trial of concomitant hyperfractionated-accelerated radiotherapy (HART) with cisplatin (Cis) plus cetuximab (Cet) for locoregionally advanced inoperable squamous cell head and neck cancer: 5-year end results

T. Kuhnt, A. Schreiber, A. Pirnasch, M.G. Hautmann, P. Hass, F.P. Sieker, R. Engenhart- Cabilic, M. Richter, K. Dellas and J. Dunst

in Annals of Oncology

Published on behalf of European Society for Medical Oncology

Volume 27, issue suppl_6 Published in print October 2016 | ISSN: 0923-7534
Published online October 2016 | e-ISSN: 1569-8041 | DOI: https://dx.doi.org/10.1093/annonc/mdw376.59
Phase II-trial of concomitant hyperfractionated-accelerated radiotherapy (HART) with cisplatin (Cis) plus cetuximab (Cet) for locoregionally advanced inoperable squamous cell head and neck cancer: 5-year end results

Show Summary Details

Journal Article.  363 words. 

Subjects: Medical Oncology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content. subscribe or login to access all content.